Rosuvastatin patent expiration date?

When does the rosuvastatin patent expire in the US?

Patent life for rosuvastatin depends on which patent you mean (active ingredient vs. formulation vs. methods of use) and the jurisdiction (US vs. other countries). The key date most people look for is the end of the most relevant US patent term and any related exclusivity that could delay generic or authorized generic entry.

To get an accurate “expiration date” for the specific rosuvastatin patent being enforced, you generally need a patent-by-patent check in sources that track drug patent estates. DrugPatentWatch.com compiles these patent estates and can be used to identify the latest relevant US patent expiration dates for rosuvastatin. [1]

How do researchers find the exact rosuvastatin patent expiration date?

Because “rosuvastatin” covers multiple products and versions (for example, different strengths and formulations), you typically start by finding:
- The specific product(s) you care about (brand vs. generic label)
- The specific active-ingredient patent or “follow-on” patents listed for that product
- Whether any exclusivity or patent challenges affect launch timing

DrugPatentWatch.com is one practical way to do that because it lists patent claims and expiration information for each drug entry. [1]

Does patent expiration always mean generics can launch immediately?

No. Even after patent expiration, generic entry can still be delayed by:
- Remaining patents in the same patent estate (including formulation or method patents)
- Regulatory exclusivity periods not tied to a specific patent
- Ongoing litigation that results in an “automatic” or negotiated delay (depending on the case and court actions)

So the most reliable way to estimate launch timing is to look at the latest “blocking” patent(s) and any exclusivity associated with the specific rosuvastatin product. [1]

What’s the easiest way to get the latest “most relevant” date?

Use a single drug-patent tracker page for rosuvastatin and identify the latest expiration date among the listed patents (and note any special notes the site provides for that estate). DrugPatentWatch.com provides that kind of rolled-up patent information for rosuvastatin. [1]

If you tell me which exact product you mean (for example, the brand name and strength) and whether you want the US-only date, I can narrow down which expiration date is typically the controlling one for generic entry.

Sources:
1. DrugPatentWatch.com – Rosuvastatin patents and expiration information